Ubs Group Ag Nls Pharmaceutics LTD Wt Pur C Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 13, 2024	BUY	$0.02 - $0.09 $100 - $452	5,023 Added 502.3%	6,023 $0
Q4 2023 Feb 09, 2024	BUY	$0.05 - $0.17 $50 - $170	1,000 New	1,000 $0
Q4 2022 Feb 08, 2023	SELL	$0.1 - $0.32 $1,180 - $3,776	-11,802 Reduced 75.91%	3,745 $1,000
Q3 2022 Nov 10, 2022	BUY	$0.1 - $0.42 $1,346 - $5,653	13,461 Added 645.3%	15,547 $4,000
Q2 2022 Aug 10, 2022	BUY	$0.06 - $0.4 $5 - $38	96 Added 4.82%	2,086 $0
Q1 2022 May 16, 2022	SELL	$0.2 - $0.5 $129 - $322	-645 Reduced 24.48%	1,990 $1,000
Q3 2021 Nov 15, 2021	SELL	$0.77 - $1.16 $547 - $824	-711 Reduced 21.25%	2,635 $2,000
Q2 2021 Aug 13, 2021	BUY	$0.72 - $1.0 $163 - $227	227 Added 7.28%	3,346 $3,000
Q1 2021 May 12, 2021	BUY	$0.65 - $1.85 $2,027 - $5,770	3,119 New	3,119 $3,000

Others Institutions Holding NLSPW

# of Institutions

8

Shares Held

632K

Call Options Held

0

Put Options Held

0

Altium Capital Management LP New York, NY

200K
Shares

$4,000
0.0% of portfolio
Ayrton Capital LLC Westport, CT

170K
Shares

$3,402
0.64% of portfolio
Empery Asset Management, LP New York, NY

150K
Shares

$3,000
0.23% of portfolio
Hudson Bay Capital Management LP Greenwich, CT

71.4K
Shares

$1,427
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

19.6K
Shares

$392
0.0% of portfolio

About NLS PHARMACEUTICS LTD WT PUR C

Ticker NLSPW

More about NLSPW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.